Concepedia

Sujith Sarvesh

SS

Statistics

Publications

4

Citations

63

H-Index

4

Active since

2023

Affiliations

University of Alabama at Birmingham(Current)

Auburn University

Augusta University Health

Samford University

University of Illinois Chicago

Sujith Sarvesh is an author at University of Alabama at Birmingham specializing in oncogenic signaling pathways, medicine, and cancer pharmacology.

ORCID

Publications per year

2023–2025

4

Publications

4

A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer

Jeremy B. Foote, Tyler Mattox, Adam B. Keeton et al. · Cancer Research · 2024 · 22 citations · Full text

, , +17

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh et al. · Molecular Cancer · 2025 · 16 citations · Full text

, , +15

Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine

Ganji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B. Foote et al. · Cell Reports Medicine · 2024 · 13 citations · Full text

, , +17

A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer

Jeremy B. Foote, Tyler Mattox, Adam B. Keeton et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 12 citations · Full text

, , +17

1–4 of 4